Skip to content

Accurate Test of Limb Isometric Strength (ATLIS) in ALS

Accurate Test of Limb Isometric Strength (ATLIS) in ALS

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02374606
Enrollment
100
Registered
2015-03-02
Start date
2015-03-31
Completion date
2020-02-29
Last updated
2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Keywords

outcomes measures, strength measurement, disease progression

Brief summary

A strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigator will compare ATLIS data with data from the commonly used ALS outcomes measure, the ALS Functional Rating Scale-Revised (ALSFRS-R), as well as an exploratory measure, electrical impedance myography (EIM), in a prospective, longitudinal study. Both outcomes measures will be performed on 100 subjects collected preferably at bi-monthly clinic visits during the study period.

Detailed description

Cedars-Sinai Medical Center will enroll and collect data on 100 subjects. Subjects will ideally be tested every 1 to 4 months according to each patient's site visit schedule. Subjects will be tested at each visit using ATLIS, the ALSFRS-R questionnaire and EIM.

Interventions

None listed

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects 18 years or older diagnosed with clinically possible, laboratory supported probable, probable or clinically definite ALS according to the World Federation of Neurology Revised El Escorial Criteria. * Capable of providing informed consent and complying with trial procedures. * Active movement of at least two limbs at the time of study entry * Intend to routinely attend clinic for neurological care at the clinical site

Exclusion criteria

* Patients, judged by the site clinical investigator to have medical conditions that may limit their ability to safely exert maximal force using the muscles in their arms and legs will be excluded from this study (e.g. unstable hypertension, significant cardiac disease, significant musculoskeletal disorders, or other medical conditions). * Patients judged by the site clinical investigator to have significant clinical evidence of unstable medical or psychiatric illness will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in Accurate Test of Limb Isometric Strength (ATLIS) between each visitevery 1 to 4 months according to each patient's site visit scheduleATLIS measures isometric strength in 12 muscle groups in the arms and legs. The subject is tested seated in a specially designed chairs with adjustable uprights. The subject's limb is placed in a standard position and maximal force is exerted on the wireless load cell fixed to the upright. Strength data is digitally captured and expressed as a percentage of expected normal.

Secondary

MeasureTime frameDescription
Change in ALS Functional Rating Scale - Revised (ALSFRS-R) between each visitevery 1 to 4 months according to each patient's site visit scheduleThis questionnaire consists of 12 questions about the subject's ability to function in certain daily activities. Questions are asked in an interview format.

Other

MeasureTime frameDescription
Exploratory measure: Electrical impedance myography (EIM) data will be compared to ATLIS data.every 1 to 4 months according to each patient's site visit scheduleEIM evaluates how electrical current flows through muscle which assists in determining muscle health by measuring electrical current in muscle. 14 muscle groups in the arms and legs will be tested in this study.

Countries

United States

Contacts

Primary ContactAshley Fetterman
katherine.fetterman@cshs.org310-423-8497

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026